Mutation spectrum of the MTM1 gene in XLMTM patients: 10 years of experience in prenatal and postnatal diagnosis.
X-linked myotubular myopathy (XLMTM) is a congenital neuromuscular disorder defined by severe hypotonia, respiratory failure and histopathologic changes in muscle biopsy. The objective of this report is to inform about our experience of genetic analysis on a group of 25 unrelated XLMTM patients, clinically diagnosed by several Italian and European Medical Institutes from 2006 to 2015. The molecular strategy used for genotyping involved Sanger sequencing of coding and intron/exon regions and the Multiplex Ligation Probe Amplification method. A total of 13 different point variants (6 nonsense, 5 missense, 1 splicing and 1 small deletion) were found in 15 patients (60%). Three were new missense variants: c.185G>T p.(Arg62Ile), c.719T>A p.(Val240Glu), and c.1262G>T p.(Arg421Leu). No large duplications/deletions have been identified. We performed carrier testing of at-risk female relatives. Only one mutation was de novo. Successively, we offered XLMTM prenatal testing for seven pregnancies in five unrelated families. In this context, the aim to propose an effective molecular diagnostic service is to confirm clinical XLMTM diagnosis, to monitor the cause-disease mutation segregation in the family and to offer genetic counseling to have correct information regarding offspring risks and the prenatal testing.
Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy.
G
G
Longo
Fondazione PTV "Policlinico Tor Vergata", U.O.C. of Medical Genetics, Rome, Italy.
S
S
Russo
Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy.|Fondazione PTV "Policlinico Tor Vergata", U.O.C. of Medical Genetics, Rome, Italy.
G
G
Novelli
Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy.|Fondazione PTV "Policlinico Tor Vergata", U.O.C. of Medical Genetics, Rome, Italy.
F
F
Sangiuolo
Fondazione PTV "Policlinico Tor Vergata", U.O.C. of Medical Genetics, Rome, Italy.
M R
MR
D'Apice
D000483:Alleles; D000595:Amino Acid Sequence; D001706:Biopsy; D004252:DNA Mutational Analysis; D005260:Female; D005820:Genetic Testing; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008969:Molecular Sequence Data; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D020914:Myopathies, Structural, Congenital / Q000175:diagnosis* / Q000235:genetics*; D010375:Pedigree; D011247:Pregnancy; D011296:Prenatal Diagnosis; D054558:Protein Tyrosine Phosphatases, Non-Receptor / Q000737:chemistry / Q000235:genetics*; D016415:Sequence Alignment
D054558:Protein Tyrosine Phosphatases, Non-Receptor; C099588:myotubularin
MLPA; MTM1 variants; XLMTM; prenatal diagnosis